Brudie LA, Khan F, Radi MJ, Ahmad S. Serous carcinoma of endometrium in combination with neuroendocrine small-cell: A case report and literature review.
Gynecol Oncol Rep 2016;
17:79-82. [PMID:
27508271 PMCID:
PMC4970543 DOI:
10.1016/j.gore.2016.07.004]
[Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2016] [Revised: 06/26/2016] [Accepted: 07/21/2016] [Indexed: 11/16/2022] Open
Abstract
Endometrial serous carcinomas are very clinically aggressive, which constitutes 40% of all deaths and recurrences associated with endometrial cancer. Small-cell carcinoma of the endometrium is relatively rare but aggressive, and often presents a component of endometrioid carcinoma, and is not generally associated with serous carcinoma. Herein, we report a case of 74-year-old African-American female, who presented with intermittent post-menopausal bleeding for > 1-month. She underwent robotic-assisted laparoscopic hysterectomy, bilateral salpingo-oophorectomy, sentinel lymph node mapping, and pelvic-and-aortic lymphadenectomy. Final pathology was consistent with serous carcinoma of the endometrium in combination with neuroendocrine small-cell carcinoma. This extremely rare combination of tumors presents a challenge for treatment. The mainstay of treatment seems to be surgery followed by chemotherapy ± radiation therapy. To our knowledge, it represents an under-reported area of gynecological medicine.
Small-cell carcinoma of endometrium is rare but aggressive and challenging to care.
We report a case presenting with intermittent post-menopausal bleeding for > 1-month.
She underwent robotic hysterectomy, BSO, SLN mapping, and complete lymphadenectomy.
Pathology revealed serous carcinoma of endometrium combined with neuroendocrine SCC.
To our knowledge, it represents an under-reported area of gynecological medicine.
Collapse